137 related articles for article (PubMed ID: 27384857)
1. [Successful high-dose dexamethasone treatment of acquired pure red cell aplasia following ABO major mismatched allogeneic hematopoietic stem cell transplantation].
Hiroshima Y; Shiono Y; Suzuki I; Yamamoto M; Kato Y; Tajima K; Kato T
Rinsho Ketsueki; 2016 Jun; 57(6):760-4. PubMed ID: 27384857
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.
Sackett K; Cohn CS; Fahey-Ahrndt K; Smith AR; Johnson AD
J Clin Apher; 2018 Feb; 33(1):108-112. PubMed ID: 28543448
[TBL] [Abstract][Full Text] [Related]
4. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
7. Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.
Chapuy CI; Kaufman RM; Alyea EP; Connors JM
N Engl J Med; 2018 Nov; 379(19):1846-1850. PubMed ID: 30403942
[TBL] [Abstract][Full Text] [Related]
8. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
9. Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
Yates B; Molloy E; Dulau-Florea A; Braylan R; Hogan L; Hickstein DD; Freeman AF; Kalsi SS; Shah NN
Transfusion; 2021 Apr; 61(4):1041-1046. PubMed ID: 33528026
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
[TBL] [Abstract][Full Text] [Related]
11. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.
Ebihara Y; Manabe A; Tsuruta T; Ishikawa K; Hasegawa D; Ohtsuka Y; Kawasaki H; Ogami K; Wada Y; Kanda T; Tsuji K
Int J Hematol; 2007 Dec; 86(5):446-50. PubMed ID: 18192114
[TBL] [Abstract][Full Text] [Related]
12. Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.
Henig I; Yehudai-Ofir D; Zohar Y; Zuckerman T
Acta Haematol; 2021; 144(6):683-687. PubMed ID: 33887733
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
14. [Pure red cell aplasia following the rapid reduction and discontinuation of cyclosporine for mixed chimerism after allogeneic bone marrow transplantation].
Okamoto K; Osone S; Saito T; Imamura T; Hosoi H
Rinsho Ketsueki; 2018; 59(11):2408-2412. PubMed ID: 30531134
[TBL] [Abstract][Full Text] [Related]
15. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
Deotare UR; Vishwabandya A; Mathews V; George B; Srivastava A; Chandy M
Bone Marrow Transplant; 2006 Jun; 37(12):1149-50. PubMed ID: 16699532
[No Abstract] [Full Text] [Related]
16. Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient.
Cockerill KJ; Lyding J; Zander AR
Eur J Haematol; 1989 Sep; 43(3):195-200. PubMed ID: 2509237
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Xu Y; Wu D; Zhong J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):61-5. PubMed ID: 12513840
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Gao Y; Gao F; Shi J; Fu H; Huang H; Zhao Y
J Zhejiang Univ Sci B; 2021 Aug; 22(8):695-700. PubMed ID: 34414703
[TBL] [Abstract][Full Text] [Related]
19. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Yamaguchi M; Sakai K; Murata R; Ueda M
Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
